What Treatments Are Available for a Brain Tumour? 

The choice of treatment for a brain tumour in the United Kingdom is determined by the tumour type, its grade, and its location, alongside the overall health of the patient. In the UK, a multidisciplinary team of specialists, including neurosurgeons and oncologists, collaborates to design a management plan that prioritises the preservation of neurological function while addressing the growth. Standard interventions often involve a combination of surgery, radiotherapy, and chemotherapy, though some slow-growing tumours may be monitored without immediate active treatment. Understanding these options within the framework of NHS and NICE guidelines provides a structured approach for patients navigating the care pathway. This article outlines the primary treatment modalities used in the UK and explains how they are integrated into a comprehensive care strategy. 

What We’ll Discuss in This Article 

• The role of neurosurgery in removing or debulking a brain mass. 

• Using radiotherapy and stereotactic radiosurgery to target abnormal cells. 

• Chemotherapy and systemic treatments for malignant tumours. 

• The active surveillance approach, also known as watch and wait. 

• Supportive medications used to manage symptoms such as swelling and seizures. 

• The importance of neurorehabilitation in long-term recovery and support. 

Neurosurgery for Removal and Diagnosis 

Surgery is the primary treatment for most brain tumours in the United Kingdom, aimed at removing as much of the abnormal tissue as safely possible. By reducing the physical size of the tumour, surgeons can alleviate pressure within the skull and improve symptoms such as headaches or physical weakness. The NHS states that surgery is often the first treatment for most brain tumours to remove as much of the tumour as possible. 

In the UK, the most common surgical procedure is a craniotomy, where a section of the skull is temporarily removed to provide access to the brain. If a tumour is located near areas controlling vital functions like speech or movement, an awake craniotomy may be performed to monitor the patient’s responses during the operation. When a tumour cannot be fully removed, a smaller procedure called a biopsy may be used instead to take a sample for analysis. The extent of the resection depends on the tumour boundaries; benign tumours often have clear edges making them easier to remove, whereas malignant tumours may infiltrate healthy tissue, requiring more cautious management. 

Radiotherapy and Stereotactic Radiosurgery 

Radiotherapy uses high-energy radiation beams to destroy tumour cells and is frequently used in the UK after surgery to treat any remaining microscopic cells. The treatment is delivered over several sessions, known as fractions, allowing healthy brain cells time to recover between doses. NICE clinical guidelines for brain tumours indicate that radiotherapy should be considered for patients with high-grade tumours or those where surgery cannot remove the entire mass. 

Radiotherapy Type	Method of Delivery	Common Use in UK
External Beam	Radiation from a machine outside the body.	Post-surgery for gliomas.
Stereotactic (SRS)	Multiple tiny beams focused on one spot.	Small tumours or deep-seated masses.
Proton Beam	Use of proton particles instead of X-rays.	Specific cases, often in children.

Stereotactic radiosurgery (SRS) is a specialised form of radiotherapy that delivers a very high, precise dose of radiation in a single session. Despite the name, it does not involve a traditional surgical incision. In the UK, SRS is typically reserved for small, well-defined tumours or when a patient is not fit for a craniotomy. All radiotherapy planning in the NHS involves creating a bespoke mask for the patient to ensure their head stays in the exact same position for every session, maximising accuracy and protecting healthy tissue. 

Chemotherapy and Systemic Treatments 

Chemotherapy involves the use of anti-cancer medications to kill tumour cells and is typically used in the UK to treat malignant tumours or those that have returned after initial management. These drugs interfere with the ability of cells to grow and divide, and they can be taken as tablets, given via an injection, or administered through a drip. 

The most common chemotherapy drug for primary brain tumours in the UK is temozolomide, which is often taken at home in capsule form. Other regimens, such as the PCV combination of procarbazine, CCNU, and vincristine, are used for specific subtypes. In rare cases, carmustine implants may be placed directly into the brain cavity during surgery to deliver treatment locally. Because chemotherapy travels through the entire body, it can cause systemic side effects like tiredness or nausea. UK oncology teams monitor patients closely with regular blood tests to ensure their immune system remains healthy throughout the treatment cycles. 

Active Surveillance and Monitoring 

For some slow-growing or benign tumours that are not causing symptoms, UK clinicians may recommend active surveillance, also known as watch and wait, rather than immediate surgery or radiation. This approach is often chosen when the risks of treatment, such as potential damage to healthy brain tissue, outweigh the benefits of removing a stable, asymptomatic mass. 

During active surveillance, the patient condition is monitored through: 

• Regular MRI Scans: Typically performed every 3 to 12 months to check for any growth. 

• Clinical Reviews: Appointments with a specialist to discuss any new or changing symptoms. 

• Symptom Monitoring: Tracking issues such as seizures or cognitive changes. 

This strategy is common for Grade 1 meningiomas or some low-grade gliomas. If the scans show that the tumour has begun to grow or if the patient develops new symptoms, the multidisciplinary team will then recommend moving to active treatment. This integrated surveillance allows many people in the UK to maintain their normal quality of life for many years without the side effects associated with more invasive procedures. 

Supportive Medications for Symptom Control 

In the United Kingdom, medication is an essential part of the care plan used to manage the symptoms caused by the tumour itself or as a side effect of other treatments. Two of the most common types of medication used are steroids and anti-epileptic drugs. The GOV.UK health pages provide clinical profiles indicating that steroids are used to reduce the swelling around a brain tumour, which can improve symptoms quickly. 

Steroids, such as dexamethasone, are used to reduce the fluid build-up known as oedema in the brain tissue. This can quickly improve symptoms like headaches, sickness, and confusion. Patients on steroids are often given a steroid card and advised not to stop the medication suddenly. Anti-epileptic drugs are prescribed to prevent or control seizures, which are a common symptom of many brain tumours. UK GPs and specialists work together to ensure these medications are balanced, as some anti-seizure drugs can affect how other treatments work. Painkillers and anti-sickness medications are also provided to manage headaches and nausea, ensuring the patient remains as comfortable as possible during their clinical journey. 

Neurorehabilitation and Long-term Support 

Following active treatment in the UK, many patients require a period of neurorehabilitation to help them recover or adapt to physical, cognitive, or speech changes caused by the tumour. This supportive care is an integrated part of the NHS pathway and involves a team of allied health professionals. 

The rehabilitation team may include: 

• Physiotherapists: To help with balance, walking, and physical strength. 

• Occupational Therapists: To assist with daily tasks and maintaining independence. 

• Speech and Language Therapists: To support communication and swallowing. 

• Clinical Psychologists: To help with the emotional and cognitive impact of the diagnosis. 

This support is provided both in hospital and in the community to ensure a smooth transition back to daily life. In the UK, the focus of long-term care is on holistic wellbeing, recognising that recovery from a brain tumour involves more than just physical healing. Patients are also given information on how to access local support groups and charities, providing a network of care that continues long after the primary treatments are completed. 

Conclusion 

Treatments for a brain tumour in the UK are diverse and tailored to the individual, ranging from surgical removal and targeted radiation to active surveillance for slow-growing masses. The NHS follows a multidisciplinary approach, ensuring that every patient benefits from a range of specialist expertise from diagnosis through to rehabilitation. While surgery remains the primary intervention for many, advanced technologies like stereotactic radiosurgery and chemotherapy provide precise options for complex cases. Effective management also includes the use of medications to control swelling and seizures, alongside long-term supportive care. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article provides medically factual health education regarding brain tumour treatments, strictly aligned with NHS and NICE clinical guidelines. The content is developed by a professional medical writing team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in general surgery and emergency medicine. All information follows current UK public health protocols to ensure clinical accuracy and patient safety.